comparemela.com

Latest Breaking News On - Nancy leone - Page 3 : comparemela.com

HARMONY BIOSCIENCES INITIATES PHASE 3 TRIAL OF PITOLISANT IN ADULT PATIENTS WITH IDIOPATHIC HYPERSOMNIA

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative.

United statesJeffrey daynoDavid burleyNancy leoneLuis sanayJohnc jacobsExchange commissionHypersomnia foundationDrug administrationPrnewswire harmony biosciences holdings incParagon biosciencesBiosciences holdingsChief medical officerChief executive officerBoard chairFull prescribing information

HARMONY BIOSCIENCES INITIATES PHASE 3 TRIAL OF PITOLISANT IN ADULT PATIENTS WITH IDIOPATHIC HYPERSOMNIA

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative.

United statesJeffrey daynoDavid burleyNancy leoneLuis sanayJohnc jacobsExchange commissionHypersomnia foundationDrug administrationPrnewswire harmony biosciences holdings incParagon biosciencesBiosciences holdingsChief medical officerChief executive officerBoard chairFull prescribing information

HARMONY BIOSCIENCES ANNOUNCES DATE OF FIRST QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and.

Nancy leoneLuis sanayCompany nasdaqPrnewswire harmony biosciences holdings incParagon biosciencesBiosciences holdingsPlymouth meetingBiosciences investor contactBiosciences media contactHarmony biosciences

HARMONY BIOSCIENCES OPENS APPLICATIONS FOR 2022 PROGRESS AT THE HEART PROGRAM

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative.

United statesNancy leoneCorporate affairs officerRare disease diversity coalitionCommunity programsPatti bankPublic healthHarmony biosciences holdings incParagon biosciencesHarmony biosciences holdingsHarmony biosciencesCate mccanlessChief corporate affairsPlymouth meetingBiosciences media contactBiosciences investor contact

HARMONY BIOSCIENCES TO PARTICIPATE IN 21st ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and.

Nancy leoneJohnc jacobsCompany nasdaqPrnewswire harmony biosciences holdings incPatti bankParagon biosciencesBiosciences holdingsAnnual needham virtual healthcarePlymouth meetingBiosciences investor contactBiosciences media contactHarmony biosciences

vimarsana © 2020. All Rights Reserved.